Feng Mao Hua
Directeur/Membre du Conseil chez LEPU BIOPHARMA CO., LTD.
Profil
Feng Mao Hua is the founder of Viva Biotech Holdings, established in 2008.
He currently holds the position of Co-Chairman at BioSyngen Pte Ltd.
and Chairman at China Finance Strategies Investment Holdings Ltd.
He also serves as an Independent Non-Executive Director at Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Shanghai NewMed Medical Co., Ltd., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd., Lepu Biopharma Co., Ltd., and Sirnaomics Ltd.
Mr. Hua previously held the position of Chief Executive Officer & Director at ChemPartner PharmaTech Co., Ltd., Chairman at Zhejiang Langhua Pharmaceutical Co., Ltd., and Independent Non-Executive Director at AGTech Holdings Ltd.
He also served as Managing Director at CLSA Ltd., Managing Director-Investment Banking at CLSA Equity Capital Markets Ltd., and Managing Director & Founding Partner at China Finance Strategies Ltd.
Mr. Hua has a Master's in Business Administration from the International University of Japan and an undergraduate and graduate degree from Shanghai International Studies University.
Postes actifs de Feng Mao Hua
| Sociétés | Poste | Début |
|---|---|---|
| SIRNAOMICS LTD. | Directeur/Membre du Conseil | 01/12/2021 |
| BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. | Directeur/Membre du Conseil | 01/07/2021 |
| LEPU BIOPHARMA CO., LTD. | Directeur/Membre du Conseil | 01/12/2021 |
Shanghai NewMed Medical Co., Ltd.
 Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | 21/07/2021 |
| China Finance Strategies Investment Holdings Ltd. | Président | 01/08/2014 |
BioSyngen Pte Ltd.
 BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore. | Président | - |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
 Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Directeur/Membre du Conseil | - |
Anciens postes connus de Feng Mao Hua
| Sociétés | Poste | Fin |
|---|---|---|
| FERRETTI S.P.A. | Directeur/Membre du Conseil | 19/02/2024 |
| VIVA BIOTECH HOLDINGS | Fondateur | 30/06/2021 |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Feng Mao Hua
| International University of Japan | Masters Business Admin |
| Shanghai International Studies University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 8 |
|---|---|
| AGTECH HOLDINGS LIMITED | Distribution Services |
| VIVA BIOTECH HOLDINGS | Health Technology |
| BOCOM INTERNATIONAL HOLDINGS COMPANY LIMITED | Finance |
| SIRNAOMICS LTD. | Health Technology |
| CHEMPARTNER PHARMATECH CO.,LTD. | Commercial Services |
| FERRETTI S.P.A. | Consumer Durables |
| BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. | Commercial Services |
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| Entreprise privées | 13 |
|---|---|
Hebei Titans Medical Supply Technology Group Co. Ltd.
 Hebei Titans Medical Supply Technology Group Co. Ltd. Medical SpecialtiesHealth Technology Hebei Titans Medical Supply Technology Group Co. Ltd. engages in the manufacture of personal hand protection products. Its products are disposable nitrile gloves and disposable vinyl gloves, which are widely used in medical care, clinical examination, chemical industry, electronics, food processing and other industries. The company was founded by Wen Xin Lu and Wei Dong Liu on February 23, 2011 and is headquartered in Xingtai, China. | Health Technology |
| China Finance Strategies Ltd. | |
CLSA Equity Capital Markets Ltd.
 CLSA Equity Capital Markets Ltd. Investment Banks/BrokersFinance Part of CITIC Securities Co., Ltd., CLSA Equity Capital Markets Ltd. provides investment management services. The company is based in Hong Kong, Hong Kong. | Finance |
| Cazenove Asia Ltd. | Finance |
ICEA Capital Ltd.
 ICEA Capital Ltd. Regional BanksFinance Part of Industrial & Commercial Bank of China Ltd., ICEA Capital Ltd. provides banking services. The company is based in Hong Kong, Hong Kong. | Finance |
Bank of America, NA (Charlotte, North Carolina)
 Bank of America, NA (Charlotte, North Carolina) Major BanksFinance Bank of America, NA engages in the provision of commercial banking services. It offers financing, checking and savings accounts, and investment banking for individual clients. The company was founded on March 1, 1927 and is headquartered in Charlotte, NC. | Finance |
CLSA Ltd.
 CLSA Ltd. Investment Banks/BrokersFinance CLSA Ltd. is the Hong Kong-based institutional brokerage subsidiary of CITIC Securities Co., Ltd. (SSE: 600030, SEHK: 6030), a full-service investment bank headquartered in China. Founded in 1986, the firm provides sales and execution services to global investors and corporates. | Finance |
BioSyngen Pte Ltd.
BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore. | Health Technology |
| Cfs Global Resources Co. Ltd. | |
| China Finance Strategies Investment Holdings Ltd. | |
Shanghai NewMed Medical Co., Ltd.
Shanghai NewMed Medical Co., Ltd. BiotechnologyHealth Technology Shanghai NewMed Medical Co., Ltd. engages in research, development, production of artificial heart valves and transcather implantation system. The company was founded by Yu QifengY in March 2015 and is headquartered in Shanghai, China. | Health Technology |
Zhejiang Langhua Pharmaceutical Co., Ltd.
 Zhejiang Langhua Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Langhua Pharmaceutical Co., Ltd. engages in the production and manufacture of active pharmaceutical ingredient and intermediate products. Its products include ciprofloxacin hydrochloride, enrofloxacin, levofloxacin hemihydrate, levofloxacin hydrochloride, spironolactone, zidovudine, canrenone, and ciprofloxacin q-acid. The company was founded in 1986 and is headquartered in Taizhou, China. | Health Technology |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sirnaomics, Inc., Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. is a Chinese company that develops nucleic acid drugs. The company is based in Suzhou, China. The company was founded in 2008 by Yang Lu, David Mark Evans. Yang Lu has been the CEO since 2008. | Health Technology |